Canada markets close in 4 hours 29 minutes

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
46.00+1.85 (+4.19%)
As of 11:31AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
15,127
8,083
8,612
3,637
0
-
Operating Expenses
Research Development
53,101
54,922
53,441
26,237
3,041
-
Selling General and Administrative
27,959
26,140
22,262
10,329
1,802
-
Total Operating Expenses
81,060
81,062
75,703
36,566
4,843
-
Operating Income or Loss
-65,933
-72,979
-67,091
-32,929
-4,843
-
Interest Expense
-
-
-
0
206
233
Total Other Income/Expenses Net
-
-
-
-
-1,735
-
Income Before Tax
-44,045
-58,293
-63,059
-32,672
-6,784
-
Income from Continuing Operations
-44,045
-58,293
-63,059
-32,672
-6,784
-
Net Income
-44,045
-58,293
-63,059
-32,672
-6,784
-
Net Income available to common shareholders
-44,045
-58,293
-63,059
-32,672
-6,784
-
Basic EPS
-1.52
-1.32
-1.52
-1.39
-0.54
-
Diluted EPS
-1.52
-1.32
-1.52
-1.39
-0.54
-
Basic Average Shares
41,470
44,016
41,470
23,530
12,473
-
Diluted Average Shares
41,470
44,016
41,470
23,530
12,473
-